Results 151 to 160 of about 29,564 (216)
Universal Cytomegalovirus Screening in the First Trimester of Pregnancy: The Multicentre Observational Cohort Study in the Area of Barcelona (CITEMB Study)
BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 5, Page 1037-1045, April 2026.ABSTRACT Objective
To determine the CMV seroprevalence among pregnant women and assess the rate of primary CMV infections during the first trimester. Design
Prospective multicentre observational cohort study. Setting
Four primary care centres (ASSIRs) and two tertiary hospitals in Barcelona and its metropolitan area. Pupulation or Sample
Pregnant women María Ángeles Sánchez‐Durán, Juliana Esperalba, Elena Scazzocchio, Irene Fernández‐Torm, Eva Vázquez‐Segura, Olga Gracia‐Salazar, Marta Calveiro‐Hermo, Jordina Munrós‐Feliu, Astrid Francesch‐Campi, Laia Alcoverro‐Bedos, Aleida Ribas‐Tristany, Cristina del Viso‐Lajara, Julia Mitjans‐Carrasco, Mercedes Guerrero‐Martínez, Gema Fernández‐Rivas, Aneta Monika Zientalska, Liudmila Liutsko, Gemma Falguera‐Puig, Cristina Martínez‐Bueno, Nerea Maiz, Roser Gol, the CITEMB group +21 morewiley +1 more sourceFamily History and Solar Insolation in Bipolar I Disorder
Acta Psychiatrica Scandinavica, Volume 153, Issue 4, Page 270-278, April 2026.ABSTRACT Background
Sunlight has profound impacts on physical and mental health, beyond vision, including effects on circadian rhythms, alertness, mood, and sleep. A family history of any mood disorders is strongly associated with psychiatric disorders including bipolar disorder.M. Bauer, T. Glenn, E. D. Achtyes, M. Alda, E. Agaoglu, K. Altınbaş, O. A. Andreassen, E. Angelopoulos, R. Ardau, M. Aydin, Y. Ayhan, C. Baethge, R. Bauer, B. T. Baune, C. Balaban, C. Becerra‐Palars, A. P. Behere, H. Belete, T. Belete, G. Okawa Belizario, F. Bellivier, R. H. Belmaker, F. Benedetti, M. Berk, Y. Bersudsky, Ş. Bicakci, H. Birabwa‐Oketcho, T. D. Bjella, C. Brady, J. Cabrera, M. Cappucciati, A. M. Paredes Castro, W. Chen, E. Y. W. Cheung, S. Chiesa, M. Chanopoulou, M. Crowe, A. Cuomo, S. Dallaspezia, P. Desai, S. Dodd, B. Etain, A. Fagiolini, F. T. Fellendorf, E. Ferensztajn‐Rochowiak, J. G. Fiedorowicz, K. N. Fountoulakis, M. A. Frye, P. A. Geoffroy, M. J. Gitlin, A. Gonzalez‐Pinto, J. F. Gottlieb, P. Grof, B. C. M. Haarman, H. Harima, M. Hasse‐Sousa, C. Henry, L. Hoffding, J. Houenou, M. Imbesi, E. T. Isometsä, M. Ivkovic, S. Janno, S. Johnsen, F. Kapczinski, G. N. Karakatsoulis, M. Kardell, L. V. Kessing, S. J. Kim, B. König, T. L. Kot, M. Koval, M. Kunz, B. Lafer, M. Landén, E. R. Larsen, R. W. Licht, V. M. Ludwig, C. Lopez‐Jaramillo, A. MacKenzie, H. Østergaard Madsen, S. Alberte Kongstad A. Madsen, J. Mahadevan, A. Mahardika, K. Mahfoudh, M. Manchia, W. Marsh, M. Martinez‐Cengotitabengoa, J. Martini, K. Martiny, Y. Mashima, D. M. McLoughlin, A. N. R. Meesters, Y. Meesters, I. Melle, F. Meza‐Urzúa, E. Michaelis, P. Mikolas, Y. Ming Mok, S. Monteith, M. Moorthy, G. Morken, E. Mosca, A. A. Mozzhegorov, R. Munoz, S. V. Mythri, R. K. Nadella, T. Nakanotani, R. Ernst Nielsen, C. O'Donovan, A. Omrani, Y. Osher, U. Ouali, M. Pantovic‐Stefanovic, P. Pariwatcharakul, J. Petite, A. Pfennig, M. Pilhatsch, Y. Pica Ruiz, M. Pinna, M. Pompili, R. Porter, D. Quiroz, F. Diego Rabelo‐da‐Ponte, R. Ramesar, N. Rasgon, W. Ratta‐apha, M. Redahan, M. S. Reddy, A. Reif, E. Z. Reininghaus, J. Gringer Richards, P. Ritter, J. K. Rybakowski, L. Sathyaputri, A. M. Scippa, C. Simhandl, D. Smith, J. Smith, P. W. Stackhouse Jr, D. J. Stein, K. Stilwell, S. Strejilevich, K.‐P. Su, M. Subramaniam, A. Hatim Sulaiman, K. Suominen, A. J. Tanra, Y. Tatebayashi, W. Lin Teh, L. Tondo, C. Torrent, D. Tuinstra, T. Uchida, A. E. Vaaler, E. Vieta, B. Viswanath, C. Volf, K.‐J. Yang, M. Yoldi‐Negrete, O. Kaan Yalcinkaya, A. H. Young, Y. Zgueb, P. C. Whybrow +163 morewiley +1 more sourceExploring the genetic overlap between substance use disorder and educational attainment
Addiction, Volume 121, Issue 4, Page 908-921, April 2026.Abstract Background and aims
Substance use disorder (SUD) is a polygenic psychiatric condition characterized by persistent drug use despite negative consequences. Several studies support that higher cognitive performance and educational attainment (EA) are associated with a reduced risk for SUD.Judit Cabana‐Domínguez, Laura Vilar‐Ribó, María Soler Artigas, Silvia Alemany, Natalia Llonga, Pau Carabí‐Gassol, Uxue Zubizarreta‐Arruti, Valeria Macias‐Chimborazo, Lara Grau‐López, Constanza Daigre, Elena Ros‐Cucurull, Raúl Felipe Palma‐Alvarez, Germán Ortega‐Hernández, Noèlia Fernàndez‐Castillo, Bru Cormand, Josep Antoni Ramos‐Quiroga, Marta Ribasés +16 morewiley +1 more sourceClinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial)
Alimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 955-966, April 2026.In the phase I/IIa GOING trial, an add‐on strategy with regorafenib followed by nivolumab showed a manageable safety profile and meaningful clinical activity in second‐line hepatocellular carcinoma, with a median overall survival of 25 months and 45% three‐year survival in sorafenib‐experienced patients.Marco Sanduzzi‐Zamparelli, Ana Matilla, José Luis Lledo, Sergio Muñoz‐Martínez, María Varela, Mercedes Iñarrairaegui, Christie Perelló, Beatriz Mínguez, Neus Llarch, Laura Márquez, Antonio Guerrero, Gemma Iserte, Andrés Castaño‐García, Laura Carrión, Marta Fortuny, Jordi Rimola, Ángeles García‐Criado, Gema Domenech, Ferran Torres, José Rios‐Guillermo, Loreto Boix, Esther Samper, Àngels Kateb, Jordi Bruix, Maria Reig +24 morewiley +1 more sourceExpansion of the Phenotypic and Genotypic Spectrum for
PRKAR1B
‐Related Marbach–Schaaf Neurodevelopmental Syndrome: A Case Series
Clinical Genetics, Volume 109, Issue 4, Page 679-696, April 2026.Comprehensive clinical description of 12 subjects with pathogenic PRKAR1B variants, including two heterozygous deletions supporting haploinsufficiency as a possible mechanism of disease, providing valuable insight into the pathophysiology of MASNS and setting a framework upon which to design future mechanistic studies of PKA signaling in brain ...Sebastian Burkart, Tarik Guzeloglu, Ana R. Soares, Irene Valenzuela, Eduardo F. Tizzano, David Gómez‐Andres, Laurent Pasquier, Marine Legendre, Camille Berges, Julien Thevenon, Marjolaine Gauthier, Caleb Heid, Elly Ranum, Joseph Shen, Michelle Frees, Michael W. Schmidtke, Caro Pilar, Christian P. Schaaf +17 morewiley +1 more source